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Abstract
Background: Mendelian randomization (MR) is a powerful tool in epidemiology that can
be used to estimate the causal effect of an exposure on an outcome in the presence of
unobserved confounding, by utilizing genetic variants that are instrumental variables
(IVs) for the exposure. This has been extended to multivariable MR (MVMR) to estimate
the effect of two or more exposures on an outcome.
Methods and results: We use simulations and theory to clarify the interpretation of
estimated effects in a MVMR analysis under a range of underlying scenarios, where a
secondary exposure acts variously as a confounder, a mediator, a pleiotropic pathway and a
collider. We then describe how instrument strength and validity can be assessed for an
MVMR analysis in the single-sample setting, and develop tests to assess these assumptions
in the popular two-sample summary data setting. We illustrate our methods using data from
UK Biobank to estimate the effect of education and cognitive ability on body mass index.
Conclusion: MVMR analysis consistently estimates the direct causal effect of an expo-
sure, or exposures, of interest and provides a powerful tool for determining causal
effects in a wide range of scenarios with either individual- or summary-level data.
Key words: Mendelian randomization, two-sample Mendelian randomization, multivariable Mendelian randomiza-
tion, Cochran’s Q statistic, instrument strength, instrument validity
Key Messages
• Multivariable Mendelian randomization (MVMR) has been introduced as a technique for estimating the causal effect
of multiple exposure variables on a health outcome with two-sample summary data. We build on this work by clarify-
ing how MVMR should be applied with individual-level data and two-sample summary data, in order to conform with
established econometric theory for multivariable two-stage least-squares analysis.
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Introduction
In many scenarios in which we wish to estimate the causal
effect of an exposure X on an outcome Y, a conventional
regression analysis can be misleading, as the observational
association between the two variables could easily be af-
fected by unobserved confounding. If genetic variants—
usually single-nucleotide polymorphisms (SNPs)—are
available that reliably predict the exposure variable but do
not have an effect on the outcome through any other path-
way, then they are valid instrumental variables (IVs) and
can be used in a Mendelian randomization (MR) analysis
to obtain unconfounded estimates of the effect of the expo-
sure on the outcome, as illustrated in Figure 1.
In many scenarios, we may wish to estimate the effect
of multiple exposures on the outcome using MR analysis,
e.g. because we believe these exposures to be closely re-
lated or because we believe one exposure may mediate the
relationship between the exposure of primary interest and
the outcome. This can be done with multivariable MR
(MVMR) in which a set of genetic variants is used to pre-
dict a set of exposure variables. However, careful consider-
ation needs to be given in such an analysis to exactly what
relationship is being estimated and how the IV assump-
tions required for MR analysis apply to a MVMR analysis.
In this paper, we build on previous work developing
MVMR methods with two-sample summary-level data1,2
and fully explain how MVMR can be implemented with ei-
ther individual-level or two-sample summary-level data,
exactly what is being estimated in a MVMR analysis and
how the IV assumptions required for MR analysis translate
to MVMR analysis. We describe existing tests that can be
used to test the IV assumptions with individual-level data
and add to the previous literature on MVMR by develop-
ing new methods to identify potential violations of the IV
assumptions with two-sample summary-level data.
MR
To state the IV assumptions more formally with reference
to Figure 1, for a single SNP Gj to be a valid IV, it must be:
IV1: associated with the exposure X (the ‘relevance’
assumption);
IV2: independent of the outcome Y given the exposure
X (the ‘exclusion restriction’); and
IV3: independent of all (observed or unobserved) con-
founders of X and Y, as represented by U (the
‘exchangeability’ assumption);
If IV1–IV3 are satisfied for a set of SNPs
G ¼ G1; . . . ;GLð Þ, then traditional IV methods can be
employed to reliably test for a causal effect of X on Y using
G, X and Y alone, without any attempt to adjust for U at
all. For example, suppose the variables G, X, U and Y are
linked via the following models:
Y ¼ b0 þ bXþU þ vy (1)
• Instrument strength and validity should be assessed in the single-sample MVMR setting using the Sanderson–
Windmeijer F-statistic and the Sargan test.
• We develop a generalized version of Cochran’s Q statistic to test for instrument strength and validity in the two-
sample summary data setting. However, these tests require knowledge of the covariance between the effects of the
genetic variants on each exposure.
• If the covariance between the effect of the genetic variants on each exposure can be either: (i) estimated from individ-
ual data, (ii) assumed to be zero or (ii) fixed at zero by using non-overlapping samples for each exposure genome-
wide association study (GWAS), then our proposed summary data Q statistics will give a good approximation of the
true (individual-level data) result.
• The causal effect estimated by Mendelian randomization (MR) and MVMR can differ. MR estimates the total causal
effect of the exposure on the outcome, whereas MVMR estimates the direct causal effect of each exposure on the
outcome.
Figure 1. Hypothesized relationship between genetic variant(s) G, modi-
fiable exposures, X1, X2 and outcome Y in the presence of unobserved
confounder U. Bi-directional arrows represent possible violations of the
IV assumptions induced by X2 that are explored in this paper.
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X ¼ p0 þ pGþU þ vx: (2)
Here, vx and vy represent independent error terms, p rep-
resents the parameter vector p1; . . . ; pL and b is the true
causal effect of X on Y we wish to estimate. We will
assume throughout this paper that G1; . . . ;GLð Þ are mutu-
ally uncorrelated (by design). A naı¨ve regression of Y on X
will not yield a consistent estimate for b because the
explanatory variable in the regression, X, is correlated
with U. However, two-stage least-squares (TSLS) estima-
tion, performed by regressing Y instead on X^—the predicted
value of X from a regression of X on G – will yield a consis-
tent estimate for b, because X^ is independent of U.3,4
TSLS relies on individual-level data, but the sharing
of such data is often impractical. In recent years, it has be-
come much more common to attempt MR analyses using
summary data estimates of SNP–exposure and SNP–out-
come associations gleaned from two independent but ho-
mogeneous study populations. The SNPs in question are
usually identified as genome-wide significant ‘hits’ in dis-
tinct genomic regions via a genome-wide association study
(GWAS) for the exposure. This is referred to as ‘two-sam-
ple summary data MR’.
Let pj and Cj represent the true association for SNP Gj
in G with the exposure and the outcome, respectively.
From Equations (1) and (2), we can link the j’th SNP-
outcome association to the j’th SNP–exposure association
via the model
C^j ¼ bp^j: (3)
It follows that the Wald estimator b^j ¼ C^ jp^ j is a consistent
estimate for b5,6 where C^j and p^j are estimates from OLS
estimation of
Y ¼ C0 þ CjGj þ y;j
and
X ¼ p0 þ pjGj þ X;j
When the SNPs are uncorrelated, taking an inverse vari-
ance weighted (IVW) average of the ratio estimates will
yield an overall estimate for b, b^IVW , that closely approxi-
mates the TSLS estimate that would have been obtained if
individual-level data were available.7
Detecting ‘weak’ instruments and ‘invalid’
instruments in MR
If assumptions IV1–IV3 are fulfilled for all SNPs in G, and
linear Equations (1) and (2) hold, then either a TSLS or
IVW analysis (with uncorrelated SNPs) will consistently es-
timate the causal effect.8–10 In order to satisfy IV1, the
SNPs in G should strongly predict the exposure X. This
can be quantified using the F-statistic from the first stage
regression of X on G. Using instruments that are jointly
only weakly associated with the exposure (i.e. which have
a small F-statistic) will result in weak-instrument bias.11
Second, SNPs should not exert a direct effect on Y, i.e.
they should not affect Y other than through X. Any such
effect would represent a violation of IV2. Horizontal plei-
otropy, where the genetic variants used as instruments
have an effect on the outcome that is not through the expo-
sure of interest, is a violation of the exclusion restriction
and could easily be responsible for such a violation in the
MR setting.10,12–14 The SNPs should also not be con-
founded by any variables that also influence the outcome.
Any confounding of this nature would be a violation of
assumption IV3. A violation of either assumptions IV2 or
IV3 is likely to lead to bias and potentially erroneous con-
clusions in both the TSLS and IVW estimates.4 The pres-
ence of potential pleiotropic effects can be evaluated using
the Sargan test15,16 using individual-level data and
Cochran’s Q statistic17–19 using summary data. The causes
and consequences of pleiotropy in MR are described in de-
tail elsewhere.1,9,10,13,14,20
In addition to assumptions IV1–IV3, there are additional
assumptions and considerations that apply to all instrumen-
tal variable estimation, including MR and MVMR. These
included the assumptions of linearity and homogeneity that
are in many settings required for obtaining a point estimate
of the causal effect. However, if this assumption is violated,
the causal null will still be respected and it will still be possi-
ble to identify whether the exposures are causally associated
with the outcome.21–23 Throughout this analysis, we assume
linearity of the relationship between the exposures and the
outcome although, if this assumption did not hold, the same
issues would apply to MVMR as apply in MR analysis,
which are discussed in detail elsewhere.24,25
MVMR
MR can be extended to estimate the effect of multiple ex-
posure variables on an outcome1 and is particularly useful
in cases where a standard MR analysis would fail due to vi-
olation of assumptions IV2 and IV3. It is also useful in
cases where two or more correlated exposures are of inter-
est and may help to understand whether both exposures
exert a causal effect on the outcome, or whether one in fact
mediates the effect of the other on the outcome.26,27
MVMR requires a set of SNPs, G, that are associated with
the exposure variables but do not affect the outcome other
than through these variables. In the same way as standard
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(single-variable) MR, these SNPs can be used to predict
each of the exposure variables in the model and these pre-
dicted values can be used to estimate the effect of the expo-
sures on the outcome in a multivariable regression
analysis. The setup for MVMR is illustrated for an analysis
involving two exposure variables (X1 and X2) in Figure 2.
The arrows linking X1 with X2 and X2 with Y have been
left bi-directional to acknowledge the fact that many un-
derlying causal relationships are possible, i.e. they could
point in either direction or be completely absent. Indeed,
many of these options will be subsequently explored.
Although it is the simplest possible MVMR setting, two
exposures suffice to illustrate all the scenarios and ideas de-
scribed in this paper. From Figure 2, we can write the fol-
lowing general model linking Y, X1, X2 and U:
Y ¼ b0 þ b1X1 þ b2X2 þU þ vy: (4)
For example, suppose that X1 and X2 are in fact inde-
pendent given G (so there is no arrow in Figure 2 between
X1 and X2) and X2 affects Y independently of X1 (so that
there is a direct arrow from X2 to Y). If true, then
Equations (5) and (6) for X1 and X2 would, jointly with
Equation (4), describe the data:
X1 ¼ p01 þ p1GþU þ vx1 (5)
X2 ¼ p02 þ p2GþU þ vx2 : (6)
The purpose of an MVMR analysis is to determine the
direct causal effect of both X1 and X2 on the outcome Y,
when conditioned on one another. Without loss of general-
ity, we will focus primarily on the effect of X1 (and the pa-
rameter b1Þ with the direct effect of X2 on Y denoted by
b2 being of secondary importance.
With individual-level data, TSLS can be implemented
with multiple exposure variables, regressing each exposure
on the full set of SNPs to yield genetically predicted
estimates for X1 and X2. The outcome Y can then be
regressed on these predicted estimates for X1 and X2
jointly to obtain consistent estimates of b1 and b2. This can
be conducted by simply using the ivreg2 command in Stata
or ivpack in R.
In the two-sample summary data setting, Burgess
et al.1,2 show how MVMR can be implemented using sum-
mary data estimates of the association between SNP j (out
of L) and the outcome, C^j; exposure X1, p^1j; and exposure
X2, p^2j, by fitting the following model:
C^j ¼ b1p^1;j þ b2p^2;j þ j: (7)
This is a straightforward generalization of the IVW esti-
mation framework.
Important considerations
To conduct an MVMR analysis, it is necessary to have at
least as many genetic instruments as there are exposures to
be instrumented in the model; this is true regardless of
whether single-sample or two-sample summary data are
used. It is possible to include genetic instruments that are
associated with more than one exposure variable, provid-
ing all of those exposure variables are included in the esti-
mation. Instruments must not, however, exert a direct
effect on the outcome, except through the included expo-
sures. There is no benefit to excluding instruments that are
only strongly associated with one exposure, as this will
lead to a loss of precision in the estimates obtained. This
also avoids any potential bias that could arise due to select-
ing instruments based on their strength.11
What quantities do MR and MVMR
estimate?
MR and MVMR target different causal effects of the expo-
sure on the outcome. In general, MR estimates the total ef-
fect of the exposure on the outcome, whereas MVMR
estimates the direct effect of each exposure on the outcome.
For example, if Figure 3 describes the truth, the total ef-
fect of exposure X1 on the outcome is the effect of X1 on
the outcome Y directly plus the effect of X1 on Y via X2,
and is equal to b1 þ ab2. The direct effect of the exposure
X1on the outcome Y is the effect X1 has on Y not via any
other exposure variables included, and so is equal to b1:
Whether or not these effects differ in general depends on
the underlying relationship between the exposures and be-
tween each exposure and the outcome. If there is no effect
of X1 on X2 or of X2 on Y, i.e. either a or b2 is equal to
zero, these effects will be the same.
Figure 2. Hypothesized relationship between genetic variant(s) G, modi-
fiable exposures, X1, X2 and outcome Y in the presence of unobserved
confounder U. Bi-directional arrows represent possible violations of the
IV assumptions induced by X2 that are explored in this paper.
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To highlight the potential differences between MR and
MVMR, and the potential benefits of MVMR, we now
consider the application of MVMR to four different sce-
narios that are commonly encountered, or at least sus-
pected, in epidemiological studies.
Each of these scenarios represents a situation in which
conventional univariable MR would produce consistent
results, given the correct set of SNPs, but in which MVMR
may estimate a different causal effect and provide benefits
when in fact some of the SNPs may have effects on more
than one exposure (thus making them invalid instruments
for a univariable MR analysis). In the first scenario, X2 is a
confounder of the relationship between X1 and Y, i.e. there
is a direct causal path from X2 to X1 and from X2 to Y.
Along with Equation (4), Equation (6) above and Equation
(8) below underlie the individual-level data:
X1 ¼ p1Gþ a2X2 þU þ vx1 : (8)
In the second scenario, X2 is a collider of the relationship
between X1 and Y, i.e. there is a direct causal path from X1
to X2 and from Y to X2. When an exposure and outcome
both influence another variable, controlling for that variable
in conventional analysis will introduce bias into the ob-
served association between the exposure and the outcome.28
This form of bias can also be understood as a form of selec-
tion bias that would occur if inclusion in the sample was de-
pendent on the value of X2.
29 Along with Equation (4)
(with b2 set to 0), Equation (5) above and Equation (9) be-
low are used to generate the individual-level data:
X2 ¼ p2Gþ a1X1 þ cyY þU þ vx2 : (9)
In the third scenario, X2 is an independent pleiotropic
pathway from G to Y. This corresponds to the scenario
first described in the previous section. Along with
Equation (4), Equations (5) and (6) above are used to gen-
erate the individual-level data.
In the fourth scenario, X2 is a mediator of the relation-
ship between X1 and Y. Along with Equation (4),
Equation (5) above and Equation (10) below are used to
generate the individual-level data:
X2 ¼ p2Gþ a1X1 þU þ vx2 : (10)
Each of these scenarios is shown in Figure 4.
Simulations
Datasets of 10 000 individuals are simulated under all four
scenarios discussed using L ¼ 30 genetic variants. The var-
iants are assumed to be uncorrelated but, for added realism
and complexity, are further subdivided into three categories:
• 10 SNPs that only predict X1: G1 (with a non-zero p1
element but zero p2 element);
• 10 SNPs that only predict X2: G2 (with a non-zero p2
element but zero p1 element);
• 10 SNPs that predict X1 and X2: G12 (with non-zero p1
and p2 elements).
G therefore represents the complete vector
G1;G2;G12ð Þ. For each scenario, the causal parameter of
interest, b1, is set to 1.
Figure 3. Illustration of the direct effect and total effect of X1 on the out-
come Y.
Figure 4. Causal diagrams for scenarios 1–4. Models referred to are the
equations above that would give the same relationship between
the instruments, exposures and outcome. G1, G2 and G12 are subsets of
the full set of SNPs G that affect X1, X2 and both exposures, respectively.
International Journal of Epidemiology, 2019, Vol. 48, No. 3 717
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For each scenario, we estimate the causal effects b1 and
b2 of X1 and X2 on Y, using a range of estimation meth-
ods. With single-sample individual-level data, we
implemented:
• OLS, both for X1 and X2 individually (i.e. univariable
regressions) and together (i.e. a multivariable
regression);
• MR for X1 and X2 individually, each time using all the
available SNPs as instruments;
• MVMR including both X1 and X2 in the same analysis;
• MR for X1 and X2 individually using only the SNPs that
are valid instruments for that exposure (G1 and G2;
respectively).
With two-sample summary-level data, we implemented:
• MR for X1 and X2 individually using all of the instru-
ments available;
• MVMR including both X1 and X2;
• MR for X1 and X2 individually using only the SNPs that
are valid instruments for the exposure.
All estimation methods are described in Supplementary
Table 1, available as Supplementary data at IJE online. In
all of the scenarios considered, the exposure variables are
strongly predicted by the instruments and the instruments
have no additional pleiotropic effects on the outcome,
other than through the exposures included in the model.
Results
Focusing our attention on exposure X1, the results from
these simulations show that MVMR always gives an unbi-
ased estimate of the direct effect of X1 on the outcome. In
the hypothetical case in which only the valid SNPs for X1
(G1) are used as instruments in a single-variable MR, the
estimated effect of X1 on Y is the total effect of a change in
X1 on the outcome. Whether the direct or total effect is of
more interest to practitioners will depend on the particular
situation being considered. In many of the scenarios ex-
plored, the direct effect equals the total causal effect; how-
ever, when X2 is a mediator of the relationship between X1
and the outcome, the direct and total effects of X1 may be
substantially different. In this scenario, MVMR is not a
form of mediation analysis, but instead estimates the direct
effect of the exposure on the outcome that does not act via
the mediator. The results from the simulations are given in
Supplementary Table 2, available as Supplementary data
at IJE online, and a summary table of what is estimated by
each method in each scenario is given in Table 1.
When conducting the univariable MR estimation with a
subset of the SNPs in G, we have, for illustration, assumed
‘oracle’ knowledge on which SNPs are valid instruments
for each exposure. This will, of course, not be possible in
practice For example, in Scenario 1, if we select SNPs be-
cause they are associated with a X1, we will select the en-
tire set G, but this will include the subset ðG2;G12), which
exerts pleiotropic effects on the outcome Y and thus biases
the analysis. Table 1 indeed shows that, when all SNPs in
G are used for a univariable MR analysis, it will deliver a
biased and inconsistent estimate of the total causal effect
of X1 on Y in Scenarios 1, 3 and 4. MVMR, by contrast,
will then provide a consistent estimator of the direct effect
of the exposure on the outcome; the consistency of IV
analysis under a range of scenarios that include those dis-
cussed here has been proved elsewhere.3,4,30 These simula-
tion results also highlight that MVMR does not introduce
bias into the results when X2 is a collider of the relation-
ship between X1 and Y. This is because the predicted value
of X2, X^2, which is not dependent on the outcome, is used
in the analysis. Of course, adjusting directly for X2, rather
than X^2, would bias the analysis. This is an important ben-
efit of MVMR.
Table 1. Summary of estimated effects for b1
Scenario/which estimand is targeted?
Method I 2 3 4
Individual-level data
OLS x x x x
Univariate MR x Direct/total x x
MVMR Direct/total Direct/total Direct/total Direct
Univariate MR—subset of SNPS Direct/total Direct/total Direct/total Total
Two-sample summary data analysis
Univariate MR x Direct/total x x
MVMR Direct/total Direct/total Direct/total Direct
Univariate MR—subset of SNPS Direct/total Direct/total Direct/total Total
When each method of estimation estimates the direct and total effects for b1 in each of the scenarios considered.
An ‘x’ represents a biased method of estimation.
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Testing the assumptions of MVMR
In the simulations above, we assumed, for clarity, that the
instruments were both strong and valid for the purposes of
an MVMR analysis. However, violation of these assump-
tions can give misleading results in practice, so it is neces-
sary to test these assumptions. We now describe how
instrument strength and validity can be scrutinized for an
MVMR analysis in the individual and two-sample sum-
mary data settings.
In addition to assumptions IV1–IV3, there are addi-
tional assumptions and considerations that apply to all in-
strumental variable estimation, including MR and
MVMR. These included the assumptions of linearity and
homogeneity, which is in many settings required for
obtaining a point estimate of the causal effect. Increasing
the number of exposures in two-sample MVMR will make
this a stronger assumption due to the increased number of
SNPs and exposures. When implementing MVMR analy-
sis, this limitation should be considered and weighed
against the benefits when deciding how many exposures to
include in the analysis. Another additional assumption,
particularly relevant to two-sample MVMR analysis, is
that all data are drawn from the same underlying popula-
tion. Throughout our analysis, we assume this to hold. The
requirement for and issues surrounding this assumption
are detailed elsewhere.31,32
The individual-level data MVMR setting
Instrument strength
In any MR analysis, the set of genetic instruments G must
be strong in order to avoid weak-instrument bias (assump-
tion IV1). In single-variable MR analysis, weak instru-
ments will bias the estimated results in the direction of the
observational estimate; however, in MVMR analysis, it is
not clear what direction the bias of the estimation result
for each exposure will take as a result of weak instru-
ments.33 It is therefore important to test the strength of the
instruments in any MVMR analysis; however, the assess-
ment of instrument strength is more complicated. It is nec-
essary for G to strongly predict both X1 and X2 (as
quantified by strong F-statistics), but not sufficient. In ad-
dition, G must also jointly predict both X1 and X2, i.e.
once the secondary exposure X2 has been predicted using
G, G must still be able to predict the primary exposure X1.
Figure 5 illustrates three scenarios (A–C) in which this may
not be the case, even when both exposures appear to be
strongly predicted individually by G and a fourth scenario
(D) in which both exposures are strongly predicted.
Joint strength can be assessed using the Sanderson–
Windmeijer conditional F-statistic,33 Fc, that is available
as part of ivreg2 in Stata. Fc is calculated in the following
manner:
• X2 is regressed on the full set of genetic instruments (and
any control variables included in the estimation) and the
predicted value of X2, X^2, is calculated;
• X1 is then regressed on X^2 (and any control variables) to
yield the TSLS estimate d^ and the residual error terms
X1  d^X2 are saved;
• the errors are then regressed on the full set of instruments
(and any control variables); the conditional F-statistic is
obtained as the F-statistic for the effect of the instru-
ments in this regression;
• the conditional F-statistic must be adjusted for a degrees-
of-freedom correction, and can be compared with the
conventional weak-instrument critical values.34
For multiple exposure variables, the first step is re-
peated for each of the exposures and all of these predicted
values are included in the regression in the second step.
This F-statistic can be compared with the standard critical
values for weak instruments; therefore, if the conditional
F-statistic for all of the exposure variables is larger than
the rule-of-thumb value of 10, then the instruments can be
considered adequately strong for the purposes of MVMR.
Instrument validity
If no pleiotropy exists amongst the genetic variants, then
each one should identify the same causal parameter. This
can be evaluated using the Sargan test.15 Specifically, it
tests whether the instruments can explain any of the varia-
tion in the outcomes that has not been explained by the
Figure 5. Potential setups of instruments and exposures. In (A) and (B),
the exposures are individually strongly predicted but are not jointly pre-
dicted. In (C), the exposures are individually strongly predicted but
weakly predicted in a joint sense. In (D), the exposures are individually
and jointly strongly predicted. Specifically: (A) G predicts X1, which is a
predictor of X2. (B) G predicts X2, which is a predictor of X1. (C) G pre-
dicts X1 and X2, which are highly correlated. (D) G predicts X1 and X2,
which are uncorrelated (given G).
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value of the exposure variables. It is calculated by the fol-
lowing steps:
• regress the outcome Y on the exposures using TSLS to
yield causal estimates b^1 and b^2;
• calculate the residual error term Y  ðb^1X1 þ b^2X2Þ and
then regress the residuals on the full set of instruments;
the Sargan test is then the sample size times the R2 of this
regression;
• evaluating with the Sargan statistic with respect to a v2
distribution with degrees of freedom equal to the number
of instruments minus the number of predicted exposure
variables (i.e. the null hypothesis that all of the instru-
ments are valid).4
This test is available as part of the ivreg2 command in
Stata and the ivpack package in R. In order to conduct this
test, the model must be over-identified, i.e. there must be
more instruments than exposure variables (so that the
degrees of freedom of the v2 test is positive).35 This
‘global’ test does not give any indication as to which of the
genetic instruments are invalid if the test rejects the null.
However, alternative methods of estimation can be used to
estimate the causal effects as long as at least 50% of the
SNPs do not have a pleiotropic effect on the outcome.36,37
The two-sample summary data setting
Assessment of instrument validity and strength is appar-
ently yet to be described in the two-sample summary data
setting that is relevant to the majority of contemporary
MR studies, and consequently it is not implemented in any
standard software. We therefore describe the necessary
procedures in fine detail so that they can be confidently
implemented by others.
Assessing instrument strength: heterogeneity is ‘good’
Suppose that all of the genetic instruments predict both ex-
posure variables, so that Equations (4), (5) and (6) hold,
but there are at least two elements of p1and p2 in
Equations (5) and (6) that differ. If true, then the model
will be at least exactly identified, i.e. there will be at least
as many independent genetic instruments (i.e. two) as there
are exposure variables to be instrumented. This implies
that
X1 ¼ d0 þ dX2 þ u1:
X2 ¼ p0 þ p2Gþ u2 (11)
must be over-identified (or equivalently miss-specified), be-
cause X2 cannot then be simply a scalar multiple, d, of X1.
Therefore, we can test for under-identification in our
estimation model by testing for over-identification in
Equation (11) using the Sargan test as described above.
The equivalence of this test with the Sanderson–
Windmeijer approach has been shown formally else-
where.38 The null of this Sargan test is that of under-
identification.
Extending this to two-sample analysis, p^1;j ¼
dp^2;j þ e1;j is analogous to Equation (11) estimated by IV
using individual-level data with X^2 predicted using G;
therefore, it should be possible to test for under-
identification in two-sample MVMR estimation by testing
for over-identification in the model p^1;j ¼ dp^2;j þ v. We
recommend that this test is conducted using a modified
version of Cochran’s Q statistic, as shown in Equation (12)
below:
Qx1 ¼
XL
j¼1
1
r2x1j
 !
p^1j  d^p^2j
 2
: (12)
The variance term for Qx1 , r
2
x1j ¼ r21j þ d^
2
r22j  2d^r12j,
where r21j is the variance of p^1;j, r
2
2j is the variance of p^2;j,
r12j is the covariance of p^1;j and p^2;j, and d^ is an efficient
estimator for d. Estimation of the r2x1j terms in practice
depends on the type of model used to obtain p^1;j and p^2;j.
When each exposure is regressed on the entire set of SNPs si-
multaneously (i.e. via multivariable regressions with an
intercept):
r21j ¼
GTGð Þ1jj
n
Xn
i¼1
v^21i; r
2
2j ¼
GTGð Þ1jj
n
Xn
i¼1
v^22i and
r12j ¼
GTGð Þ1jj
n
Xn
i¼1
v^1i v^2i;
where n is the number of subjects and v^1i; v^2ið Þ are the esti-
mated residuals from these regressions. If p^1j and p^2j are
obtained separately (i.e. via univariable regressions with an
intercept), then the error terms are obtained from the
equivalent expressions are
r21j ¼
GTj Gj
 1
n
Xn
i¼1
v^21ij; r
2
2j ¼
GTj Gj
 1
n
Xn
i¼1
v^22ij and
r12j ¼
GTj Gj
 1
n
Xn
i¼1
v^1ij v^2ij:
Respectively, v^1ij and v^2ij are the estimated residuals
from the j’th regression.
Under the null hypothesis that the instruments do not con-
tain enough information to predict both exposure variables,
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Qx1 will be asymptotically v
2
L1 distributed when d is esti-
mated using an asymptotically efficient estimator, where L is
the number of instruments. Rejection of the null hypothesis
(i.e. detection of ‘heterogeneity’) indicates that the model we
wish to estimate is identified for X1.
All the above can be repeated for X2 by swapping the roles
of p^1and p^2 and calculating an equivalent Q statistic for
X2, Qx2 say. If both Qx1 and Qx2 are larger than the chosen
critical value, then the null hypothesis of under-identification
can be rejected and the test suggests that the instruments can
predict variation in both exposures. Table 2 shows the distri-
bution of Qx1 and Qx2 for four different scenarios with two
exposure variables and L ¼ 100SNPs. X1 and X2 are both
functions of a set of SNPs and independent confounding vari-
ables. In the first simulation, the model has been set up as
given in Scenario 3 in Figure 4 and in Figure 5D with each of
the exposure variables predicted by a set of SNPs and a com-
mon confounding variable. This model is identified as both
exposure variables can be predicted by the set of instruments.
In the second and third simulations, the model has been set
up in the same way but with no effect of the SNPs on either
X1 or X2, respectively, i.e. the model is under-identified with
one of the exposure variables not being predicted by the
instruments in each case. In the final simulation, the model
has been set up with the effect of the SNPs on the exposures
as given in Figure 5A and a common confounder. This setup
leads to neither exposure being predicted by the SNPs when
they are both included in an MVMR estimation, as the SNPs
in the model cannot predict both of the exposure variables
jointly. The results from these simulations show that this test
has the required distribution under the null hypothesis.
Testing instrument validity: heterogeneity is ‘bad’
Cochran’s Q statistic for the regression of interest has been
proposed as a method for identifying the presence of
invalid instruments (e.g. due to horizontal pleiotropy) in
two-sample summary data MR analysis, with a single ex-
posure.19 Specifically, if all instruments are valid IVs, and
the modelling assumptions necessary for two-sample MR
are satisfied, then each genetic instrument should give the
same estimate of the effect of the exposure on the outcome.
Excessive heterogeneity in the causal-effect estimates
obtained by each SNP individually now becomes an indica-
tor of invalid instruments. We propose testing for invalid-
ity in two-sample summary data MVMR using an adjusted
version of the Cochran Q statistic given by:
QA ¼
XL
j¼1
1
r2Aj
 !
C^j  b^1p^1j þ b^2p^2j
  2
: (13)
Where r2Aj ¼ r2yj þ b^
2
1r
2
1j þ b^
2
2r
2
2j þ 2b^1b^2r12j. To clarify,
r2yj is the variance of C^j, and b^1 and b^2 are efficient esti-
mates of b1 and b2 [e.g. as obtained from fitting Equation
(7)]. Under the null hypothesis that the genetic instruments
do not have pleiotropic effects on the outcome, QA is as-
ymptotically v2 distributed with ðL 2Þ degrees of freedom.
The standard implementation of Cochran’s Q would merely
have a weighting of r2yj, and is not therefore asymptotically
v2 distributed. It is a straightforward generalization of the
adjusted Q statistic recently proposed by Bowden et al. in
the univariable MR setting.18 Excessive heterogeneity in QA
therefore brings assumptions IV2 and IV3 into doubt.
Figure 6 shows the distribution of QA compared with
the standard Q statistic and a v2 distribution with 98
degrees of freedom for a model with two exposure varia-
bles and 100 genetic instruments. For simplicity, the esti-
mated effects of the SNPs on the exposures each have a
common variance of 0.02 and have a common covariance
of 0. QA is seen to have the correct distribution under the
null hypothesis of no pleiotropy in the model.
Table 2. The distribution of the modified Q statistic as a test for under-identification
Qx1 Qx2
Mean Std. dev Rej. rate (%) Mean Std. dev Rej. rate (%)
x1 strongly identified 1 953 018 26 441 100 1 952 738 247 541 100
x2 strongly identified
x1 unidentified 99.3 14.6 6.2 379 282 135 506 100
x2 strongly identified
x1 strongly identified 453 058 1 607 136 100 100.2 14.6 6.6
x2 unidentified
x1 strongly identified 100.2 14.6 6.6 100.2 14.6 6.6
x2 strongly identified
Jointly unidentified x1 ¼ dx2, d ¼ 1
N¼50 000. Repetitions¼ 1000, 100 SNPs as instruments. Rejection rates give the proportion of times each Q statistic is larger than the 95th percentile of a
Chi-squared distribution on 99 degrees of freedom (123.2).
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We suggest updating the two-sample causal estimates in
an iterative process using weights derived from the initial
estimates of the causal effects, which is referred to as ‘mod-
ified iterative’ weighting in Bowden et al.18 within the con-
text of a univariate MR analysis. Further work is required
to fully investigate the effect of this and to understand how
the fully analytical solution discussed in,18 which finds
that the causal estimate that directly minimizes an equiva-
lent Q statistic could be extended to the multivariable case
but, if done so, this could help to mitigate the effect of
weak-instrument bias.
Approximating Qx1; Qx2 and QA with incomplete
information
The covariance vector r12j that is necessary for correct
specification of Qx1; Qx2 and QA can only be calculated
from the individual participant data. If this information is
not available, one solution would be to ensure that r12j is
zero, by estimating the genetic associations with each ex-
posure and the outcome in separate samples. This would
correspond to a ‘three-sample’ summary data MR
analysis when two exposures constitute the MVMR
analysis.
Another pragmatic solution would be to assume that
each r12j term is zero. This will give a good approximation
for Qx1 and Qx2 whenever dr12j is small and for
QA whenever b^1b^2r12j is small.
Application to education, cognitive ability
and body mass index (BMI)
In this section, we apply the methods discussed above to in-
vestigate whether there is evidence for a causal effect of ed-
ucation and cognitive ability on BMI using data from UK
Biobank. Education and cognitive ability have both been
Figure 6. The distribution of the adjusted and standard Q statistics under the null hypothesis of no heterogeneity. 5000 repetitions, 100 SNPs. Here,
b1¼ b2¼ 1. r1j 2¼r2j2¼ 0.02, r12j¼ 0 for a.
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found to be associated with BMI, with higher levels of edu-
cation and cognitive ability being associated with lower
levels of BMI.39–42 However, there is also a high level of
correlation observed between completed education and
measured cognitive ability; therefore, it is not clear
whether, once this correlation has been controlled for,
both education and cognitive ability have a causal effect on
BMI.39
Data
UK Biobank recruited 502641 individuals aged 37–
73 years between 2006 and 2010 from across the UK.
Individuals were invited to a clinic where they answered a
questionnaire and interview about a range of health topics
and provided anthropomorphic measurements and gave
samples of blood, urine and saliva. This study has been de-
scribed in full previously.43
Individuals in UK Biobank were asked to report the
highest educational qualification they had obtained. For
each individual, we assigned an age at which they left edu-
cation based their reported qualification. A breakdown of
educational qualifications and associated ages across the
cohort is given in Supplementary Table 3, available as
Supplementary data at IJE online.
Cognitive ability was measured among a subset of the
UK Biobank participants as the number of correct answers
recorded in a series of 13 questions designed to measure
cognitive ability that where completed as part of the initial
clinic. The cognitive ability variable was then
standardized to have mean zero and variance 1. BMI was
calculated based on the height and weight of the
individuals in the sample. Throughout the analysis, we
analysed this variable on the natural log scale because of
its skewed distribution.
Analysis
We first conducted MR analyses for the effect of
education and cognitive ability on BMI separately
using single-variable MR. A single composite instrument
for education was created using the polygenic score of
74 SNPs from a recent GWAS of educational attainment.44
A single composite instrument for cognitive ability was cre-
ated using the polygenic score of 18 SNPs from a
recent GWAS of cognition.45 As this GWAS was
conducted using the interim release of UK Biobank, we re-
stricted our analysis to individuals not included in the in-
terim release.
We then conducted a multivariable MR analysis of the
effect of education and cognitive ability on BMI. This
analysis included both the composite instruments for edu-
cation and cognitive ability used in the single-variable MR
analyses.
The results from this analyses, along with a multivari-
able OLS regression of BMI on education and cognitive
ability, are given in Table 3. The OLS results show that
each extra year of education is associated with a decrease
in BMI. MR and MVMR results suggest a causal effect in
the same direction, but with a larger magnitude. The
results for cognitive ability are more mixed, with no associ-
ation seen in the OLS results, a negative total effect of cog-
nitive ability on BMI in the MR analysis and potentially a
positive direct effect of cognitive ability on BMI observed
Table 3. The effect of education and cognitive ability on BMI
OLS MR
Single variable Multivariable Single variable Multivariable
Age completed education Effect –0.008 –0.008 –0.028 –0.044
Std. error (0.0003) (0.0003) 0.005 0.013
95% CI [–0.0095, –0.0074] [–0.0085, –0.0074] [–0.0391, –0.0179] [–0.0704, –0.0187]
F-statistic 188.2 195.0
S-W F-statistic 35.7
Standardized cognitive ability score Effect –0.006 0.0001 0.048
Std. error (0.0007) (0.0007) 0.008 0.025
95% CI [–0.0078, –0.0051] [–0.0013, 0.0014] [–0.0380, –0.0082] [–0.001, –0.098]
F-statistic 542.2 309.7
S-W F-statistic 37.0
Dependent variable is log(BMI).
Estimates of the effect of education and cognitive ability on BMI from OLS, single-variable MR and multivariable MR analysis of individual-level data.
All regressions also include a full set of control variables: age, gender, income and 10 genetic principal components.
Instruments are constructed from GWAS scores for education and cognitive ability. The regressions are weighted so that individuals who left school at 15 are
given an 80% up-weighting. All non-European and related individuals have been excluded from the analysis. Total sample size included in all regressions: 74 309.
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in the MVMR analysis. Our empirical and theoretical in-
vestigation helps to clarify why the the high level of corre-
lation between education and cognitive ability would lead
to the conclusion that there is a negative effect of cognitive
ability on BMI in MR analysis. The MVMR results show
that, if anything, the direct effect of increasing cogntive
ability is to increase BMI. These results highlight the po-
tential benefits of MVMR. However, before giving much
credence to this result, it is necessary to assess the strength
of our SNPs to jointly predict education and cognitive
ability.
Testing the instrument strength in the single-
sample setting
As a measure of the strength of the instruments, we calculate
the standard F-statistic for both education and cognitive abil-
ity and the Sanderson–Windmeijer partial F-statstic33 for the
multivariable MR analysis. As all F-statistics are much
larger than the rule-of-thumb cut-off of 10, we are reassured
that the instruments are not individually weak. However, the
partial F-statistic for both education and cognitive ability is
significantly lower, showing that the power of the instru-
ments to predict both variables simultanously is greatly
reduced.
The Sargan test for invalid instruments can only be cal-
culated for estimation models with more instruments than
exposure variables. In this estimation, we have two expo-
sures and two instruments and so it is not possible to calcu-
late the Sargan statistic.
Two-sample MVMR
To illustrate two-sample MVMR, we randomly divided the
sample used for the individual analysis into three equally
sized groups. For each SNP used in the polygenic score, we
then calculated its effect on log(BMI), education and cogni-
tive ability using different parts of the sample. The results
were then used to conduct a two-sample MVMR analysis.
The results are given in Supplementary Table 4, available
as Supplementary data at IJE online. They show that in-
creased education has a direct effect that decreases BMI and
cognitive ability has no direct effect on BMI. The results are
in line with those obtained from the individual-level
analysis.
Testing instrument strength in the two-sample
setting
To test for weak instruments in this analysis, we have calcu-
lated the weak-instrument Q statistics for education and
cognitive ability. The Qedu statistic for education is 1724.4.
The Qcog statistic for cognitive ability is 1488.8. The critical
value for a v2 distribution with 88 degrees of freedom at the
5% level is 110.9. Therefore, we reject the null hypothesis
that the SNPs do not explain any of the variation in the
exposures education and cognitive ability in this two-sample
analysis and can conclude that these SNPs can predict both
education and cognitive ability in the data.
Testing for pleiotropy in the two-sample setting
To illustrate the two tests for pleiotropy discussed earlier, we
report the QA statistic for MVMR. The value of QA for this
regression is 129.5. The critical value for a v2 distribution with
87 degrees of freedom is 109.77. Therefore, the null hypothesis
that there is no heterogeneity is rejected for this value of QA.
Multivariable MR Egger regression
An alternative procedure that has been recently proposed
to adjust for pleiotropy beyond that explainable by geneti-
cally predictable exposures (e.g. X1 and X2) is a
multivariable MR Egger regression.46 This is a natural ex-
tension of the original MR Egger approach1 and is calcu-
lated by fitting the two-sample MVMR model with a
constant included:
C^j ¼ b0 þ b1p^1j þ b2p^2j þUYj þ vYj
If the constant is different from zero, this suggests that
additional pleiotropy is meaningfully biasing the analysis.
However, a generalization of the InSIDE assumption is re-
quired in order for it to deliver unbiased causal estimates.
These are described in detail elsewhere.1
The two-sample results were used to fit multivariable MR
Egger regression, the results of which are given in
Supplementary Table 5, available as Supplementary data at
IJE online. Its intercept parameter is estimated to be small,
and consequently the estimated effects of the exposures do
not differ from those in the two-sample MVMR estimation.
This supports the suggestion that the SNPs do not exert a di-
rect effect on BMI apart from through education or cognitive
ability. As MR Egger is dependent on the orientation of the
SNP–exposure associations, we repeated this analysis with
the associations orientated so that the SNP education associa-
tions where all positive and then with the SNP cognitive abil-
ity associations all positive. These changes had no substantive
effect on the results obtained.
The difference between the Q statistic and multivariable
MR Egger estimation suggests an inconsistency between
these two tests, although this may have arisen due to a
high level of variation in the effect of the SNPs on each ex-
posure leading to a higher Q statistic. This is supported by
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Figure 7A and B, which give individual MR plots for each
exposure and show that there is a large amount of varia-
tion of the SNPs on each of the exposures. Repeating this
analysis with the outlying SNP excluded makes no substan-
tive difference to the results obtained.
The MVMR Egger analysis was repeated using the ef-
fect of each SNP on education, cognitive ability and BMI
taken from GWAS estimates.44,45,47 The magnitude of the
estimated effects differ in this analysis, as the outcome var-
iable is BMI rather than the natural log of BMI, although
these results also show no pleiotropic effect of the SNPs on
the outcome and a negative effect of higher education on
BMI. Results from this analysis are given in Supplementary
Table 5, available as Supplementary data at IJE online.
Discussion
In this paper, we have attempted to explain the principled
application and interpretation of instrumental variable
analysis to the epidemiological setting with multiple expo-
sures. We first focused on the individual data setting, for
which it is possible to borrow well-established methods
(and related software) from the econometrics literature.
We then considered the two-sample setting and built upon
previous research in this area by developing new tests for
assessing the validity and relevance of the genetic instru-
ments. In particular, we propose two new tests:
• modified Q statistics (in our case Qx1 and Qx2) for in-
strument relevance that detect ‘good’ heterogeneity if a
set of SNPs can jointly and reliably predict all intermedi-
ate exposures of interest;
• a modified Q statistic, QA for instrument validity that
detects ‘bad’ heterogeneity if a set of SNPs contains inva-
lid instruments.
We finally illustrated the application of MVMR using in-
dividual- and summary-level data to estimate the effect of
education and cognitive ability on BMI. The results from
this analysis show that increasing education leads to lower
BMI and the size of this effect increases when cognitive abil-
ity is controlled for. Comparing the single-exposure MR
analysis results (with all SNPs that affect educational attain-
ment excluded) with the MVMR results for cognitive ability
shows a large change in the size and direction of the effect.
This result suggests that education is a mediator of the rela-
tionship between cognitive ability and BMI and any direct
effect of cognitive ability on BMI is minimal.
The methods we describe can be used to estimate the
effect of multiple related exposures on an outcome using
either individual-level or summary-level data. Although we
have focused on the case of two exposures for ease of
explanation, all of these methods can be easily applied to
scenarios with three or more exposures. An advantage of
MVMR analysis is that SNPs that are thought to poten-
tially affect multiple exposure variables, or where it is not
clear exactly which exposure they affect, can be included
when estimating the effects of the exposures on the out-
come. This makes MVMR particularly useful when the
exposures are closely related or one (or more) is thought to
be a potential pleiotropic pathway from the SNPs to the
outcome. MVMR will also produce consistent estimates
when there is measurement error in any of the exposure
variables and therefore is a useful method of analysis when
multiple exposure variables are thought to be subject to
measurement error.
As with all MR analysis, it is important to ensure that the
IV assumptions are satisfied. Here, we explain how the IV
assumptions apply to a MVMR analysis. We describe exist-
ing tests that can be used to test the assumptions in
individual-level data and propose tests that can be used with
Figure 7. Left: MR Egger plot for the association between educational attainment and BMI. Right: MR Egger plot for the association between cognitive
ability and BMI. All SNPs that affect either education or cognitive ability are included.
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two-sample summary-level data. These new tests are a key
strength of this work, as MVMR cannot be effectively used
as part of the tools a researcher has available for analysis un-
less the potential pitfalls of the analysis are well understood.
Our applied results highlight the importance of considering
the IV assumptions in the context of the particular analysis
being conducted as, even when the instruments appear to be
very strong for each of the exposures individually, this does
not guarantee that they will be equally as strong for the expo-
sures when estimated jointly in a MVMR model. For exam-
ple, the F-statistics decrease from 195 and 310 to 36 and 37
for educational attainment and cognitive ability, respectively.
A practical limitation of the new tests we develop for
two-sample summary data MVMR is the reliance on knowl-
edge of the covariance between the effect of the SNP on each
exposure. These results are not available in conventional
GWAS results, and it would be infeasible to calculate them
in advance for every possible combination of exposure vari-
able that could be included in a MVMR model.
Unfortunately, our work shows that this information is
strictly needed for valid inference. In order to conduct these
tests in summary-level data, we therefore have to make a
choice about how to treat these missing pieces of informa-
tion. If the data were available, it can be directly calculated
from the individual -level data for the particular MVMR
study being conducted. Alternatively, it could be assumed to
be zero, or set to zero by using non-overlapping GWAS stud-
ies for each exposure, as the standard error of the estimated
SNP effects will not correlate across different samples. This
is an important limitation of the results given here for testing
the assumptions of two-sample summary data MVMR.
Another weakness of the instrument relevance test we de-
velop is that this is a test for whether the SNPs can condition-
ally explain any of the variation in the exposure variables,
rather than being a more usual weak-instrument test, such as
the rule of thumb of F being greater than 10 for a univariable
MR analysis or the Sanderson–Windmeijer conditional F-
statistic for IV analysis with individual-level data. Extending
this test to weak instrument is an area for future work.
Supplementary data
Supplementary data are available at IJE online.
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